Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

(Melle-4)cyclosporin

Base Information Edit
  • Chemical Name:(Melle-4)cyclosporin
  • CAS No.:143205-42-9
  • Molecular Formula:C62H111 N11 O12
  • Molecular Weight:1202.61
  • Hs Code.:
  • UNII:96262S4I14
  • DSSTox Substance ID:DTXSID70904006
  • Nikkaji Number:J614.992H
  • Wikipedia:NIM811
  • Wikidata:Q6954330
  • Metabolomics Workbench ID:144435
  • ChEMBL ID:CHEMBL1688529
  • Mol file:143205-42-9.mol
(Melle-4)cyclosporin

Synonyms:(melle-4)cyclosporin;9-(N-methyl-L-isoleucine)-cyclosporin A;9-(N-methylisoleucine)cyclosporin A;NIM 811;NIM-811;NIM811;SDZ NIM 811;SDZ NIM811;SDZ-NIM-811;SDZ-NIM811

Suppliers and Price of (Melle-4)cyclosporin
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • ChemScene
  • NIM811 98.82%
  • 5mg
  • $ 1188.00
  • ChemScene
  • NIM811 98.82%
  • 1mg
  • $ 336.00
Total 29 raw suppliers
Chemical Property of (Melle-4)cyclosporin Edit
Chemical Property:
  • Vapor Pressure:0mmHg at 25°C 
  • Boiling Point:1293.6°Cat760mmHg 
  • PKA:13.32±0.70(Predicted) 
  • Flash Point:736.2°C 
  • PSA:292.76000 
  • Density:1.018g/cm3 
  • LogP:3.93790 
  • XLogP3:7.5
  • Hydrogen Bond Donor Count:5
  • Hydrogen Bond Acceptor Count:12
  • Rotatable Bond Count:15
  • Exact Mass:1201.84136802
  • Heavy Atom Count:85
  • Complexity:2330
Purity/Quality:

99%, *data from raw suppliers

NIM811 98.82% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)CC)C)C
  • Isomeric SMILES:CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)[C@@H](C)CC)C)C
  • Recent ClinicalTrials:Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients
  • Recent EU Clinical Trials:A randomized, adaptive-design dose finding study to assess the antiviral efficacy and
Post RFQ for Price